Bladder Management With Chronic Indwelling Catheter is Associated with Elevated Mortality in Patients with Spinal Cord Injury - 14/07/22
, Juan Peng 2, Marilly Palettas 2, YuYing Chen 3, Michael J. DeVivo 3, Jan M. Schwab 4Résumé |
Objective |
To evaluate the impact of bladder management method, specifically chronic indwelling catheter (IndC), on survival in patients with spinal cord injury (SCI) in Spinal Cord Injury Model System database.
Methods |
Spinal Cord Injury Model System is a multicenter longitudinal database since 1970 with >40,000 patients with SCI. Adult patients (>18 at the time of injury) were screened. Patients who died within 1 year of injury and had 2 or more changes in method of bladder management, or reported normal volitional void were excluded. Outcome of interest was death from nonpulmonary, nonwound related sepsis (NPNWS). Left truncation cox regression method using age as the time-scale was used to calculate hazard ratios.
Results |
A total of 13,616 patients were included. Comparison was performed between “IndC” group (n = 4872; 36.1%) vs “Other” (n = 8744; 63.9%). After adjusting for age and change in bladder management method, “IndC” is associated with elevated NPNWS mortality (2.10; 95% confidence interval 1.72-2.56, P < .001). Multivariable analysis, adjusting for age at injury, gender, race, education, insurance status, etiology of SCI, injury level, neurologic impairment level, and change in bladder management method, showed IndC was associated with significantly higher risk of death from NPNWS compared to other methods of bladder management.
Conclusion |
In a large cohort of SCI patients, bladder management with IndC is predictive of significantly propagated NPNWS related mortality compared to other methods of bladder management. While identifying IndC is an independent mortality risk factor, a better understanding of the underlying mechanisms could inform strategies to improve neurourological care and survival after SCI.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Nima Baradaran received paid consultant from Boston Scientific Corp. The remaining authors declare that they have no relevant financial interest. |
|
| Funding Support: The work of J.M.S. is supported by the National Institute of Disability, Independent Living and Rehabilitation Research (NIDILRR Grant 90SI5020), the National Institutes of Neurological Disorders-NIH (Grant R01 NS118200-01), theEuropean Union (EU Era Net – Neuron Program, SILENCE Grant 01EW170A), the Craig H Neilsen Foundation (Grant 596764), the Wings for Life Spinal Cord Research Foundation, and the William E. Hunt and Charlotte M. Curtis endowment. J.M.S. is a Discovery Theme Initiative Scholar (Chronic Brain Injury) of the Ohio State University. |
Vol 165
P. 72-80 - juillet 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
